Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 14, 2014
Politics & Policy

India caps prices of 50 CV and diabetes drugs

BioCentury | May 4, 2009
Clinical News

Lovenox enoxaparin regulatory update

BioCentury | Apr 28, 2008
Clinical News

Lovenox enoxaparin regulatory update

BioCentury | Apr 25, 2008
Company News

Impurity found in enoxaparin

BioCentury | Feb 4, 2008
Clinical News

Lovenox enoxaparin regulatory update

BioCentury | Aug 27, 2001
Finance

Ebb & Flow

BioCentury | Aug 23, 2001
Clinical News

AMI data for Genentech's TNKase

Items per page:
1 - 8 of 8